Press-release for stocks related to als

Prices are updated after-hours

tags : Als crawled time : 19:00

save search

Coya Therapeutics to Participate in the 3rd Annual ALS Drug Development Summit
Published: 2024-04-18 (Crawled : 19:00) - biospace.com/
COYA | News | $8.28 3.24% 3.14% 120K

| -1.84% | O: -1.1% H: 0.0% C: 0.0%
drug als therapeutics development

National Institutes of Health Awards $45.1 Million NINDS Grant for CNM-Au8® Study in ALSFunding to Support Research and Expanded Access of Investigational Drug in ALS
Published: 2023-10-05 (Crawled : 19:00) - biospace.com/
CLNN 4 | $0.3374 0.69% 0.68% 300K

| -31.19% | O: 4.43% H: 27.91% C: 5.31%
au8 drug health als awards research grant study

Denali Therapeutics Announces DNL343 Interim Phase 1b Data in ALS and Entry into the HEALEY ALS Platform Trial
Published: 2022-12-05 (Crawled : 19:00) - biospace.com/
DNLI | $15.55 -3.48% -3.6% 840K

Health Technology

| -50.63% | O: 1.01% H: 0.09% C: -6.13%
dnl343 als trial therapeutics platform phase 2b

Intraligamentary Injection: Efficacy of the Computer-Controlled Injection System STA, the Ligamaject, and the dental syringe for intraligamentary anesthesia in restorative patients” 2009 International Dentistry, South Africa; Ferrari M, et al.
Published: 2022-03-22 (Crawled : 19:00) - milestonescientific.com
MLSS A | $0.559 0.34% 0.0% 38K

Health Technology

| -56.92% | O: -1.78% H: 1.82% C: -1.32%
system injection international als africa

Implantology: Effectiveness of Computer-Assisted Anesthetic Delivery System (STATM) in Dental Implant Surgery: A Prospective Study” 2017 Oral and Implant Surgery; Grassi FR, et al.
Published: 2022-03-22 (Crawled : 19:00) - milestonescientific.com
MLSS A | $0.559 0.34% 0.0% 38K

Health Technology

| -56.92% | O: -1.78% H: 1.82% C: -1.32%
implant system als

Eledon Pharmaceuticals to Report Fourth Quarter and Full Year 2021 Financial Results on Thursday, March 24, 2022Management to host conference call and webcast at 4:30 pm ET
Published: 2022-03-17 (Crawled : 19:00) - biospace.com/
ELDN | $1.96 -9.26% -10.2% 100K

Manufacturing

| -34.35% | O: 0.0% H: 5.78% C: 4.26%
day als financial results conference report results

Norfolk Southern to present at J.P. Morgan 2022 Industrials Conference
Published: 2022-03-11 (Crawled : 19:00) - prnewswire.com
NSC | $236.22 -3.6% 0.0% 2.4M

Transportation

| Email alert Add to watchlist
als trials trial conference

The Valspar Championship Announces Tampa General Hospital as the Official and Exclusive Health Care Provider
Published: 2022-03-10 (Crawled : 19:00) - prnewswire.com
MS | News | $93.85 0.1% 0.0% 4.8M

Finance

| 9.46% | O: 1.82% H: 0.0% C: 0.0%
health als

Ayala Pharmaceuticals to Present at the 32nd Annual Oppenheimer Healthcare Conference
Published: 2022-03-09 (Crawled : 19:00) - biospace.com/
AYLA | $0.5036 5.84% -0.7% 0

Health Technology

| -86.46% | O: 2.96% H: 6.01% C: 0.78%
health als thc conference

Air Products' Chairman, President and Chief Executive Officer to Speak at J.P. Morgan Industrials Conference on March 16
Published: 2022-03-09 (Crawled : 19:00) - prnewswire.com
APD | $234.68 0.42% 0.0% 1.3M

Process Industries

| 2.96% | O: -1.56% H: 2.0% C: 1.85%
als air trials trial conference

New Science 37® CNS Survey Confirms Growing Trend in Clinical Trials LandscapeWithin CNS indications, data suggest Agile Clinical Trials™ and decentralized approaches will become more prevalent in 2022 and beyond
Published: 2022-03-01 (Crawled : 19:00) - biospace.com/
SNCE | $5.75 0.26% 49K

| -29.69% | O: -1.35% H: 2.99% C: -8.46%
als trials trial clinical trials growing

Amylyx Pharmaceuticals Announces EMA Validation of Marketing Authorisation Application (MAA) for AMX0035 for the Treatment of ALS
Published: 2022-02-25 (Crawled : 19:00) - biospace.com/
AMLX A | $1.88 -3.59% -3.72% 1.4M

| -93.51% | O: 0.73% H: 5.65% C: 2.31%
amx0035 treatment ema als application

Construction Chemicals Market in Southeast Asia to grow by USD 1.39 Billion| Technavio
Published: 2022-02-25 (Crawled : 19:00) - prnewswire.com
RPM | $107.93 0.06% 0.0% 600K

Process Industries

| 31.74% | O: 0.61% H: 0.0% C: 0.0%
DOW | $56.98 0.42% 0.0% 4.9M

Process Industries

| -3.63% | O: -0.8% H: 0.0% C: 0.0%
als

Amylyx Pharmaceuticals Expands Executive Team with Appointment of Gina M. Mazzariello as Chief Legal Officer and General Counsel
Published: 2022-02-23 (Crawled : 19:00) - biospace.com/
AMLX A | $1.88 -3.59% -3.72% 1.4M

| -93.5% | O: -3.54% H: 5.46% C: 0.1%
als

Pieris Pharmaceuticals To Host Full-Year 2021 Investor Call and Provide Corporate Update on March 1, 2022
Published: 2022-02-23 (Crawled : 19:00) - biospace.com/
PIRS | $11.88 1.64% 1.62% 40K

Health Technology

| 285.81% | O: 1.32% H: 5.21% C: -1.95%
als

Ayala Pharmaceuticals Announces Completion of Enrollment in Part A of RINGSIDE, a Pivotal Phase 2/3 Study of AL102 in Desmoid TumorsInterim Results expected mid-2022
Published: 2022-02-23 (Crawled : 19:00) - biospace.com/
AYLA | $0.5036 5.84% -0.7% 0

Health Technology

| -88.61% | O: -4.52% H: 7.35% C: -4.98%
al102 phase 2 als phase 2/3 enroll

Baked Salmon with Citrus Salsa
Published: 2022-02-22 (Crawled : 19:00) - limoneira.com
LMNR 4 | $20.105 2.0% 1.96% 41K

Process Industries

| 35.93% | O: 0.62% H: 0.0% C: -0.62%
als citrus

Panbela Therapeutics, Inc. to Acquire Cancer Prevention Pharmaceuticals, Inc.
Published: 2022-02-22 (Crawled : 19:00) - biospace.com/
PBLA | News | $0.42 -6.31% 64K

Professional, Scientific, and T...

| -80.56% | O: 6.02% H: 4.8% C: -13.97%
als therapeutics cancer

Armata Pharmaceuticals Announces Clearance of Investigational New Drug Application to Initiate Phase 2 Clinical Trial of AP-PA02 in Non-Cystic Fibrosis Bronchiectasis
Published: 2022-02-22 (Crawled : 19:00) - biospace.com/
ARMP | $2.5 -1.19% 0.0% 4.9K

Health Technology

| -49.5% | O: -0.2% H: 6.55% C: 1.6%
pa02 new drug phase 2 als clearance fibrosis application drug trial cystic fibrosis

Missouri Selected For Nation's Premier Waste-to-Renewable Chemicals Facility
Published: 2022-02-18 (Crawled : 19:00) - prnewswire.com
CHWY 4 | $15.09 -3.27% 0.27% 8.6M

Retail Trade

| Email alert Add to watchlist
renewable als